© 2007 American Public Health Association DOI: 10.2105/AJPH.2005.084103
Marilyn Hravnak, Chester B. Good, and Said A. Ibrahim are with the Center for Health Equity Research and Promotion, Pittsburgh Veterans Affairs Health System, University of Pittsburgh, Pittsburgh, Pa. Jeff Whittle is with the University of Kansas Medical Center, Kansas City. Mary E. Kelley is with Emory University, Atlanta, Ga. Susan Sereika is with the Center for Research and Evaluation, School of Nursing, University of Pittsburgh, Pittsburgh. Joseph Conigliaro is with the University of Kentucky Medical Center, Lexington. Correspondence: Requests for reprints should be sent to Marilyn Hravnak RN, PhD, School of Nursing, University of Pittsburgh, 3500 Victoria Street, 336 Victoria Building, Pittsburgh PA 15261 (e-mail: mhra{at}pitt.edu).
Objectives. We examined whether symptoms of coronary heart disease vary between Black and White patients with coronary heart disease, whether presenting symptoms affect physicians revascularization recommendations, and whether the effect of symptoms upon recommendations differs in Black and White patients. Methods. We interviewed Black and White patients in Pittsburgh in 1997 to 1999 who were undergoing elective coronary catheterization. We interviewed them regarding their symptoms, and we interviewed their cardiologist decision-makers regarding revascularization recommendations. We obtained coronary catheterization results by chart review. Results. Black and White patients (N=1196; 9.7% Black) expressed similar prevalence of chest pain, angina equivalent, fatigue, and other symptoms, but Black patients had more shortness of breath (87% vs 72%, P=.001). When we considered only those patients with significant stenosis (n=737, 7.1% Black) and controlled for race, age, gender, and number of stenotic vessels, those who expressed shortness of breath were less likely to be recommended for revascularization (odds ratio=0.535; 95% confidence interval=0.375, 0.762; P<.001), but there was no significant interaction with race. Conclusions. Black patients reported shortness of breath more frequently than did White subjects. Shortness of breath was a negative predictor for revascularization for all patients with significant stenosis, but there was no difference in the recommendations by symptom by race.
Coronary revascularization interventions are used to relieve the symptoms of individuals with coronary heart disease (CHD) and improve quality of life.1,2 Given that the death rate from CHD is higher in Black individuals,3 it might be expected that cardiac interventions would be used at least as frequently in Black patients as in White patients. However, numerous studies have documented significantly lower revascularization rates in Black patients,4–7 even when this procedure appears to be clinically indicated.8 The reasons for this disparity include factors at the patient, provider, and system levels.7 Some studies suggest that Black patients are more likely to express CHD symptoms other than typical chest pain.9 Symptom presentation may affect referrals for catheterization or revascularization recommendations. However, the link between race and symptom expression is not well delineated nor is the relation between symptoms and revascularization recommendations. We sought to determine whether there was a difference in CHD subjective symptoms expressed by Black and White patients referred for elective cardiac catheterization and whether symptom differences affected revascularization recommendations. Such information may help to elucidate known racial differences in revascularization rates.
Participants and Data Collection We evaluated patients at 1 Veterans Affairs (VA) and 1 non-VA hospital in Pittsburgh. Trained study personnel evaluated all Black and White patients scheduled for cardiac catheterization between November 1997 and June 1999 for eligibility. We excluded patients who were scheduled for elective revascularization after previous catheterization (typically at a referring hospital), had a cardiac transplant, appeared acutely ill, or were undergoing primary emergency angioplasty. A research assistant approached consecutive eligible outpatients in the holding area for same-day procedures, except when multiple simultaneous procedures prevented all outpatients from being approached, in which case patients who appeared to be Black (by physical characteristics as determined by the research assistant) were preferentially approached. Inpatients were approached on the day preceding their scheduled procedure. We did not attempt to enroll individuals who were acutely ill, were continuously attended to by health care providers, or appeared unable to provide informed consent. Each participating hospitals institutional review board approved the study protocol. After the patients gave informed consent and were enrolled, the trained research assistants (2 Black men, 4 White women, 1 White man) interviewed them while they awaited catheterization. The interview included questions about each persons demographics and health status. Race was assigned according to participant self-report. Participants were coded as Black if they described themselves as Black as a single race or 1 of 2 races and White if they provided a description consistent with European ancestry. For example, Italian was converted to White, but American was considered unknown.
To assess symptoms of heart disease, we asked participants, "Do you currently or have you had in the past any problems related to your heart or symptoms of heart trouble?" Positive responses generated the follow-up question, "What problems or symptoms?" Particpants were asked to specifically respond yes or no to the symptom categories chest pain, shortness of breath, heart attack, need to limit activities, ability to work affected, or "other." Subjects were free to mention as many symptoms or problems as they wished. Responses of "other" were recorded verbatim by the research interviewers. The first 50 verbatim responses were read by 2 physician investigators who developed new categories based on these responses and then independently assigned each of the "other" verbatim responses to 1 of these new categories or to 1 of the original categories. Discrepancies between the investigators were resolved by consensus or recourse to a third investigator. This process continued for the remaining responses. The investigators were blinded to the participants race throughout. Examples of the full range of the verbatim responses that were eventually recoded are provided in Table 1
To examine the impact of physical symptoms on care provider recommendations, we focused only on subjective physical symptoms that patients attributed to their heart disease—chest pain, angina equivalent, shortness of breath, fatigue, and "other symptoms" (numbness, muscle cramps)—and chose not to include and analyze responses that named diagnostic terms (heart attack, arrhythmia, coronary artery disease, congestive heart failure), interventions or tests, or functional limitations that did not specify a physical symptom. Following the catheterization, we surveyed the physician who would or did make a revascularization recommendation (or gave a referral to a surgeon to consider coronary artery bypass grafting). To improve participation, we did not ask the cardiology attending faculty at the non-VA hospital to complete the questionnaire when a percutaneous intervention was completed during the index catheterization; we assumed that they had recommended the procedure and coded a yes response. However, they were asked to complete the questionnaire when the intervention was not completed as a part of the catheterization procedure. At the VA facility, where the respondent was typically a cardiology fellow, the questionnaire was used in all cases regardless of whether an intervention was completed as part of the catheterization. Almost all physician interviews took place after initial discussion of the catheterization results with the patient. We asked, "Did you recommend that this patient undergo revascularization or have a cardiothoracic surgery consult for potential revascularization at this time?" Response options were yes or no. Trained research assistants, under physician supervision, reviewed each participating physicians written catheterization report to collect data regarding coronary anatomy and stenosis. Significant stenosis was defined as 70% or greater stenosis of any single epicardial vessel or greater than 50% stenosis of the left main coronary artery. We categorized coronary disease severity as (1) severe (significant stenosis of left main artery or 3 vessels), (2) moderate (significant stenosis of 1–2 vessels and involving the proximal left anterior descending artery), (3) mild (significant stenosis of 1–2 vessels and no involvement of the proximal left anterior descending artery), or (4) no significant disease (no significant stenosis in any artery). This system for categorizing coronary disease severity has been widely used in studies evaluating the appropriateness and necessity of catheterization and revascularization.10–13 Left ventricular ejection fraction (LVEF), determined by left ventriculogram (dye contrast evaluation of percentage of left ventricular end diastolic volume ejected per beat), was recorded when available.
Analysis
Baseline Characteristics and Symptom Expression Of 1300 eligible patients participating, 1196 were coded as being Black or White and reporting at least 1 symptom and were included in the analysis. Baseline characteristics of Black (n = 116, 9.7%) and White (n = 1080, 90.3%) participants are summarized in Table 2
Considering the entire study population, patients were most likely to complain of shortness of breath (73.8%), followed by chest pain (71.8%), angina equivalent (26%), "other" symptoms (11.4%), and fatigue (5.9%). Comparisons for race, gender, age, and disease severity for patients with and without each symptom are displayed on the left side of Table 3
When we examined only the 837 patients with at least 1 significant stenosis (Table 3
Revascularization Recommendations We then considered a subsample of only patients with significant stenosis on catheterization, report of a symptom, and a revascularization recommendation (n = 737; Blacks, n = 52, 7.1%; Whites, n = 685, 92.9%). This subsample was similar to the general study population in demographic characteristics, with no between-race differences in education (P = .621), current employment (P = .962), income satisfaction (P= .508), and rating of general health (P= .056), but these participants were still different in age (P = .036) and marital status (P = .006); gender was similar between the races (P = .065). When only patients with significant stenosis were considered, there were no significant differences between Black (50%) and White (56.9%) patients being recommended for revascularization (P= .331).
We then used logistic regression to analyze predictors for revascularization recommendations in this subsample of patients. The left column in Table 4
The right column of Table 4 2Model =24.75; df =5; P =.001) and that the model fit the data well ( 2HL =4.19; df =8; P=.839). In the second block, the symptoms were entered, and this model was also significant ( 2Model =45.38; df =10; P <.001) and had a good fit to the data ( 2HL =4.417; df =8; P=.818). Even after the we controlled for the covariates, shortness of breath remained a negative predictor for a recommendation to revascularize (OR=0.535; 95% CI=0.375, 0.762; P<.001). The category of "other" symptoms (OR=0.532; 95% CI=0.306, 0.924; P=.025) was also significant, but the number of patients reporting other symptoms was small (n=60). Finally, there was no 2-way interaction for shortness of breath by race (OR=0.799; 95% CI=0.161, 3.951; P=.783) or for race and any other symptom (chest pain, P=.389; angina equivalent, P=.894; "other," P=1.000; fatigue, P=1.000). The multivariate regression analysis was repeated to test for gender and symptom interactions, but there were no significant interactions.
In a cohort of Black and White patients awaiting catheterization, Black patients reported a significantly higher prevalence of shortness of breath. Complaining of shortness of breath was a negative predictor for having a revascularization procedure recommended, even when only patients with significant stenosis were considered. However, the lesser likelihood for patients with shortness of breath being recommended for revascularization did not vary by race.
Baseline Characteristics and Symptom Expression Our findings of racial differences in the symptoms expressed by patients with CHD have also been described by others, although not consistently and never in a population in which the coronary anatomy was as well defined as in ours. Richards et al. examined 40 Black and 191 White patients with a final diagnosis of angina (66.2%) or acute myocardial infarction (33.8%).14 As in our study, Black patients were more likely to have shortness of breath than were White patients (60% vs 36%; P= .004), but no between-group differences existed in chest pain, chest heaviness, or tightness or squeezing in the chest. Black patients in their study were still more likely to have shortness of breath after demographic and clinical characteristics were controlled (OR = 3.16; 1.49, 6.71; P= .003). Raczynski et al.15 did not report a higher prevalence of shortness of breath per se in Black patients with CHD, but when symptoms were clustered into painful or not painful, Black patients were less likely to report painful symptoms and were less likely to attribute their symptoms to a cardiac origin even after control for factors other than race. Klingler et al. also found Black patients more likely to attribute symptoms to a noncardiac cause.19 However, Crawford et al. found no racial differences in shortness of breath or chest pain or in the rates of help seeking for chest pain or shortness of breath.20 Differences in study findings may relate to different methods used to assess symptoms (open-ended questionnaires, symptom categorization by researchers, symptom scales). Although gender (women21,22) and comorbidities (diabetes23 and hypertension24) have been shown to affect clinical presentation, our small sample size did not permit examination of subsets based on these characteristics. Although it seems from previous research and our results that Black and White patients with CHD have some differences in symptom complaints, it is not clear why. Cultural, educational, and socioeconomic differences may exist in the perception or reporting of pain or in patients explanatory models of disease15,25,26 It is also possible that racial differences in the type of arterial dysfunction and, in turn, the degree and location of the arterial occlusion produced, account for some of the variance. It has been reported that Black patients have a greater prevalence of arterial fatty streaks, whereas White patients have more arterial fibrous plaques.27 Several authors report that White patients have a greater prevalence of atherosclerotic calcification,28–30 whereas Black patients have more pronounced arterial intimal thickness.31 These differential manifestations may produce large and discrete proximal arterial occlusions in White patients but more diffuse narrowing of distal arteries and arterioles in Black patients, in turn causing differences in expressed symptoms. It remains unknown whether these physiologic differences are attributable to a genetic cause, are linked to ethnic variation in CHD risk factors that are in turn mediated by socioeconomic and environmental conditions, or are caused by interactions among all of these variables.
Symptoms and Revascularization Recommendations There are several possible reasons for these findings. Perhaps shortness of breath is a distracter for the provider, suggesting other diagnoses or comorbid conditions with increased procedural risk. Because the revascularization involves a dialogue with the patient, providers may be less likely to recommend the procedure for patients who are more willing to attribute their symptoms to a noncardiac cause.15 Improving understanding of the impact of symptom expression on treatment decisions is important. Although the lesser likelihood that Black patients will undergo CHD treatment is well described in the literature,5,8,17,35–37 the degree to which treatment decisions are affected by how patients express symptoms or by how patients, and in turn providers, attribute expressed symptoms to causation warrants further study.
Limitations Second, our symptom categorizations may be too simplistic. Possibly patients with fast or irregular breathing described their symptom as shortness of breath, whereas the cardiac symptom of interest is really difficult breathing or dyspnea. We also asked patients to relate "problems related to your heart or symptoms of heart trouble." Some patients may not have recognized that symptoms other than chest pain can be cardiac related and thus did not volunteer nonpainful symptoms. We also recorded more than 1 symptom. Asking the participant to choose 1 predominant symptom might help clarify how a symptomatic chief complaint affects recommendations. A third limitation is that more comprehensive data regarding past medical history and comorbidities might have identified contraindications to revascularization that would explain the associations we found. However, because all patients in the study were undergoing elective catheterization, it is likely that both the referring physicians and the physicians performing the procedure believed the patient to be free of a comorbid contraindication to performing at least percutaneous revascularization if warranted. We also doubt that severe underlying heart failure precluding revascularization was the reason that shortness of breath was a negative predictor for revascularization, because the mean LVEF for patients with and without shortness of breath was similar (shortness of breath yes, LVEF 58.1% vs shortness of breath no, LVEF 57.8%; P=.878). A fourth potential limitation is that participants were under the clinical care of the study cardiologists making the recommendations, so there was no blinding. Possibly, the physicians rated the clinical significance of the catheterization results differently by race. In addition, other patient factors, such as socioeconomic status, level of education, previous compliance with appointments and regimens, insurance, and communication style known to the physicians might have affected their recommendations through conscious or unconscious bias. Finally, our analysis examining prediction of revascularization recommendations by symptoms by race for patients with significant stenosis may have been underpowered. We enrolled only 52 Black patients with significant stenosis into this segment of the analysis, with even smaller numbers in some of the model cells for symptoms, which may have contributed to our inability to detect interactions between symptoms and race.
Conclusions
This study was supported by the National Institute of Nursing Research (1KO1NR008560), Veterans Affairs Health Services Research and Development (ECV 97-026), and American Heart Association (965063310). Thanks are extended to Denise Miller, RN, MSN, for her assistance.
Human Participant Protection
Peer Reviewed
Contributors Accepted for publication June 20, 2006.
1. Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KA, RITA-3 Trial Investigators. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol. 2005:45:221–228. 2. Norris CM, Saunders LD, Ghali WA, et al. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol. 2004;20:1259–1266.[Web of Science][Medline] 3. US Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington DC: US Government Printing Office; 2000. 4. Ibrahim SA, Whittle J, Bean-Mayberry B, Kelley ME, Good C, Conigliaro J. Racial/ethnic variations in physician recommendations in cardiac revascularization. Am J Public Health. 2003;3:1689–1693. 5. Funk M, Ostfeld AM, Chang VM, Lee FA. Racial differences in use of cardiac procedures in patients with acute myocardial infarction. Nurs Res. 2002;51: 148–157.[CrossRef][Web of Science][Medline] 6. Sharis PJ, Cannon CP, Rogers WJ, et al. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation in myocardial infarction (the TIMI III registry). Am J Cardiol. 2002;90:1154–1156.[CrossRef][Web of Science][Medline] 7. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002. 8. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of Black and White patients with high-risk non-ST elevation acute coronary syndromes. Insights from CRUSADE. Circulation. 2005;111:1225–1232. 9. Lee H, Bahler R, Park O, Kim C, Lee HY, Kim Y. Typical and atypical symptoms of myocardial infarction among Black, Whites and Koreans. Crit Care Nurs Clin N Am. 2001;13:531–539.[Medline] 10. Bernstein SJ, Laouri M, Hilborne LH, et al. Coronary angiography: a literature review and ratings of appropriateness and necessity. Santa Monica, Calif: Rand Corp; 1992. 11. Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH. Percutaneous transluminal coronary angioplasty: a literature review and ratings of appropriates and necessity. Santa Monica, Calif: RAND Corp: 1991. Also available at: http://www.rand.org/pubs/joint_reports-health/2006/JRA01.pdf. Accessed February 16, 2007. 12. Leape LL, Hilborne LH, Kahan JP, et al. Coronary artery bypass grafting: a literature review and ratings of appropriateness and necessity. JRA-02. Santa Monica, Calif, RAND Corp; 1992. 13. Leape LL, Hilborne LH, Park RE, et al. The appropriateness of use of coronary artery bypass graft surgery in New York State. JAMA. 1993;269: 753–760. 14. Richards SB, Funk M, Milner KA. Differences between Blacks and Whites with coronary heart disease initial symptoms and delay in seeking care. Am J Crit Care. 2000;9:237–244.[Abstract] 15. Raczynski JM, Taylor H, Cutter G, Hardin M, Rappaport N, Oberman A. Diagnoses, symptoms and attribution among Black and White inpatients admitted for coronary heart disease. Am J Public Health. 1994; 84:951–956. 16. Whittle J, Conigliaro J, Good B, Hanusa BH, Macpherson DS. Black-White differences in severity of coronary artery disease among individuals with acute coronary syndromes. J Gen Intern Med. 2002;17: 876–882.[CrossRef][Web of Science] 17. Conigliaro J, Whittle J, Good CB, et al. Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors. Arch Int Med. 2000;160:1329–1335. 18. Oddone EZ, Horner RD, Sloane R, et al. Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy. Stroke. 1999;30:1350–1356. 19. Klingler D, Green-Weir R, Nerenz D, et al. Perceptions of chest pain differ by race. Am Heart J. 2002; 144:51–59.[CrossRef][Web of Science][Medline] 20. Crawford SL, McGraw SA, Smith KW, McKinlay JB, Pierson JE. Do Blacks and Whites differ in their use of health care for symptoms of coronary heart disease? Am J Public Health. 1994;84:957–964. 21. Sheps DS, Kauffman PG, Sheffield D, et al. Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: results from the TIMI study. Am Heart J. 2001;142: 864–871.[CrossRef][Web of Science][Medline] 22. McSweeney JC, Cody M, Crane PB. Do you know them when you see them? Womens prodromal and acute symptoms of myocardial infarction. J Cardiovasc Nurs. 2001;15:26–38.[Medline] 23. Funk M, Naum JB, Milner KA, Chyun D. Presentation and symptom predictors of coronary heart disease in patients with and without diabetes. Am J Emerg Med. 2001;19:482–487.[CrossRef][Web of Science][Medline] 24. Molzer G, Finsterer J, Krugler W, Stanek G, Strollberger C. Possible causes of symptoms in suspected coronary heart disease but normal angiograms. Clin Cardiol. 2001;24:307–312.[Web of Science][Medline] 25. Folsom AR, Sprafka JM, Luepker RV, Jacobs DR Jr. Beliefs among black and white adults about causes and prevention of cardiovascular disease: the Minnesota Heart Survey. Am J Prev Med. 1988;4:212–127. 26. Davis IJ, Brown CP, Allen F, Davis T, Waldron D. African-American myths and health care: the sociocultural theory. J Natl Med Assoc. 1995;87:791–794.[Medline] 27. Strong JP, McGill HC Jr. The natural history of aortic atherosclerosis: relationship to race, sex and coronary lesions in New Orleans. Exp Mol Pathol. 1963; 52(suppl 1):15–27.[Medline] 28. Lee TC, OMalley PG, Feuerstein I, Taylor AJ. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in Black and White patients. J Am Coll Cardiol. 2003;41:39–44. 29. Doherty TM, Tang W, Dascalos S, et al. Ethnic origin and serum levels of 1 alpha, 25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation. 1997;96:1477–1481. 30. Newman AB, Naydeck BL, Whittle J, Sutton-Tyrell K, Edmunowicz D, Kuller LH. Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol. 2002;22:424–430. 31. Manolio TA, Burke GL, Psaty BM, et al. Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. J Clin Epidemiol. 1995;48:1141–1152.[CrossRef][Web of Science][Medline] 32. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283:3223–3229. 33. Manhapra A, Canto JG, Barron HV, et al. Under-utilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: role of presentation and evaluation characteristics. Am Heart J. 2001;142:604–610.[CrossRef][Web of Science][Medline] 34. Sheffield D, Kirby DS, Biles PL, Sheps DS. Comparison of perception of angina pectoris during exercise testing in Blacks versus Whites. Am J Cardiol. 1999;83:106–108.[CrossRef][Web of Science][Medline] 35. Petersen LA, Wright SM, Petersen ED, Daley J. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care. 2002; 40(suppl 1):I86–I96.[Medline] 36. Venkat A, Hoekstra J, Lindsell C, et al. The impact of race on the acute management of chest pain. Acad Emerg Med. 2003;10:1199–1208.[CrossRef][Web of Science][Medline] 37. Hannan EL, van Ryan M, Burke J, et al. Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Med Care. 1999;37:68–77.[CrossRef][Web of Science][Medline] 38. Okelo S, Taylor AL, Wright JT, Gordon N, Mohan G, Lesnefsky E. Race and decision to refer for coronary revascularization. J Am Coll Cardiol. 2001;38: 698–704. This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||